With increased access to HIV treatment, patient care has improved dramatically, yet HIV programs worldwide continue to see a significant proportion of patients presenting to care with advanced disease (CD4 < 200). As a priority group in the latest WHO ART guidelines, these patients require prompt yet careful management to prevent deadly opportunistic infection and to initiate and keep patients in care.
Immediate and informed action in these situations can save patient lives in both the short and long run, making an understanding of the risks and knowledge of the tools available absolutely necessary for providers and patients alike. This session will give healthcare providers, laboratorians, pharmacists, program planners and patients a better understanding of specific risks.
Dr Meg Doherty – World Health Organization
Greg Greene – Centers for Disease Control and Prevention
- Opening remarks - Making advanced disease a priority by Dr Meg Doherty, World Health Organisation
- The changing face of advanced disease by Dr Eric Goemare, Médecins Sans Frontières
- Adapting Tuberculosis Care for advanced patients by Dr Salome Charalambous, Aurum Institute
- Methods of infection prevention in advanced HIV care by Dr Francesca Conradie, Southern Africa HIV Clinicians Society
- Integrating Cryptococcal Screening into HIV Care: The Namibian story by Francina Kaindjee-Tjituka, Namibian Ministry of Health and Social Sciences
- Cervical Cancer and AIDS-related malignancies by Dr Masangu Mulongo, Right to Care
- Implementation Researc Priorities: A PEPFAR perspective by Drs Ray Chimatra and Ola Oladinyimbo, CDC and USAID - South Africa
Venue: Session room 13